Hadassah

Hadassah Transplant Center Reopens, Completes Complex Liver Transplant

Tuesday, May 5 2015

Dr. Hadar Merhav

A liver transplant operation, which lasted nine hours, was executed successfully at Hadassah Medical Organization (HMO) last week. This is the first liver transplant procedure performed since the transplant unit resumed full activity.

The patient, a 56-year-old male who suffers from a serious disease, had been waiting for the past two years to find a suitable liver. He is in stable condition.

The team at the HMO transplant unit was led by Dr. Hadar Merhav and assisted by Prof. Gidi Zamir and Dr. Ram Elazari. Dr. Merhav said of the procedure: "The patient suffered from advanced stage liver disease and the transplant was complex. I’m very pleased that the teamwork went smoothly, without any unpredictable complications and that the new liver is functioning.”

Hadassah’s transplant unit recently returned to its normal activity, approved by Prof. Rafi Beyar, Chairman of the steering committee of the National Transplant Center.

Hadassah is centralizing transplants in a single center, which will take care of patients requiring transplants of any kind. This new clinic will allow Hadassah to concentrate all of the experts under one roof, including social workers, nephrologists, surgeons, and cardiologists. The center will take advantage of the facilities of the new advanced operating rooms that are scheduled to be ready at HMO over the next few months.

Interim Director General of Hadassah, Prof. Tamar Peretz, emphasized that around 30 transplants a year were completed at HMO over the past several years and the results passed every international standard. "Hadassah is committed to the continuation of the transplant center as an essential public service, a symbol of excellency and a magnet for academic research," Prof. Peretz said.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Large Hadassah Study Identifies Predictor of Greater Risk of End-Stage Renal Disease

The findings of a nationwide study of over a million and a half Israeli adolescents, conducted by researchers at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, suggest that kidney disease in childhood is associated with a significantly increased risk of end-stage renal disease (ESRD) in adulthood, even if kidney function seems normal in adolescence.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More